Medlife revenue up 165% to Rs 363 cr, losses surge too

BENGALURU: India's largest e-pharmacy company, Medlife, posted 165% growth in revenue to Rs 363 crore in the year ended March 31, 2019, while losses surged by 145% to Rs 404 crore.

The company, run by the family behind pharmaceutical major Alkem Laboratories, saw healthy revenue growth, but expenditure on advertising and employee expenses shot up significantly during the year, according to regulatory filings ET has accessed.

The company’s advertising promotional expenses shot up to Rs 128 crore from Rs 35 crore a year earlier, while employee benefits nearly doubled to Rs 107 crore.


In August, Medlife appointed former Myntra CEO Ananth Narayanan as CEO and cofounder, with a mandate to head day-to-day operations, raise funds and oversee mergers and acquisitions at the firm.

Medlife, which competes with multiple e-pharmacies including 1mg, Netmeds, PharmEasy, was founded in 2014 by Tushar Kumar, son of Prabhat Narain Singh, one of the founders of Alkem Laboratories, and Prashant Singh.